Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Tax Provisions (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Tax Provisions for 4 consecutive years, with $3181.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions changed N/A to $3181.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44042.0 through Dec 2025, up 278.04% year-over-year, with the annual reading at $44042.0 for FY2025, 278.04% up from the prior year.
  • Tax Provisions for Q4 2025 was $3181.0 at bioAffinity Technologies, roughly flat from $3182.0 in the prior quarter.
  • The five-year high for Tax Provisions was $28984.0 in Q2 2025, with the low at -$1.0 in Q4 2022.
  • Average Tax Provisions over 4 years is $5653.1, with a median of $3181.5 recorded in 2025.
  • The sharpest move saw Tax Provisions soared 229400.0% in 2023, then tumbled 68.93% in 2024.
  • Over 4 years, Tax Provisions stood at -$1.0 in 2022, then skyrocketed by 229400.0% to $2293.0 in 2023, then increased by 11.6% to $2559.0 in 2024, then rose by 24.31% to $3181.0 in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $3181.0, $3182.0, and $28984.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.